Susquehanna International Group, LLP Keros Therapeutics, Inc. Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

A detailed history of Susquehanna International Group, LLP transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 9,048 shares of KROS stock, worth $134,724. This represents 0.0% of its overall portfolio holdings.

Number of Shares

9,048

Previous 8,382 7.95%

Holding current value

$134,724

Previous $383,000 37.08%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$41.68 - $58.07 $27,758 - $38,674	666 Added 7.95%	9,048 $525,000
Q2 2024 Aug 15, 2024	SELL	$44.58 - $66.89 $313,976 - $471,106	-7,043 Reduced 45.66%	8,382 $383,000
Q1 2024 May 07, 2024	SELL	$41.26 - $70.48 $4,414 - $7,541	-107 Reduced 0.69%	15,425 $1.02 Million
Q4 2023 Feb 14, 2024	BUY	$27.12 - $41.05 $421,227 - $637,588	15,532 New	15,532 $617,000
Q2 2023 Aug 11, 2023	SELL	$37.26 - $51.01 $662,594 - $907,110	-17,783 Reduced 66.97%	8,770 $352,000
Q1 2023 May 16, 2023	BUY	$41.44 - $59.32 $768,546 - $1.1 Million	18,546 Added 231.62%	26,553 $1.13 Million
Q4 2022 Feb 14, 2023	SELL	$39.45 - $51.77 $1.11 Million - $1.45 Million	-28,015 Reduced 77.77%	8,007 $384,000
Q3 2022 Nov 14, 2022	BUY	$27.8 - $40.12 $1 Million - $1.45 Million	36,022 New	36,022 $1.36 Million
Q2 2022 Aug 15, 2022	SELL	$26.03 - $67.04 $521,771 - $1.34 Million	-20,045 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$42.12 - $59.36 $114,229 - $160,984	2,712 Added 15.65%	20,045 $1.09 Million
Q4 2021 Feb 14, 2022	BUY	$36.95 - $62.89 $161,841 - $275,458	4,380 Added 33.81%	17,333 $1.01 Million
Q3 2021 Nov 15, 2021	BUY	$29.27 - $43.71 $123,812 - $184,893	4,230 Added 48.49%	12,953 $512,000
Q2 2021 Aug 11, 2021	BUY	$42.4 - $70.11 $369,855 - $611,569	8,723 New	8,723 $370,000
Q1 2021 May 17, 2021	SELL	$54.0 - $75.28 $345,492 - $481,641	-6,398 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$36.0 - $82.74 $230,328 - $529,370	6,398 New	6,398 $451,000

Others Institutions Holding KROS

# of Institutions

174

Shares Held

30.3M

Call Options Held

76.8K

Put Options Held

View Full List

About Keros Therapeutics, Inc.

Ticker KROS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,757,000
Market Cap $384M
Description
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...

More about KROS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Keros Therapeutics, Inc. Transaction History